SCHEMBL20014212

SCHEMBL20014212

O=C(CCCl)c1ccc(O)c(O)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 5/20 0.56
▸ SELL P14151 1/20 0.52
▸ SELP P16109 1/20 0.52
▸ HDAC1 Q13547 1/20 0.44
▸ MAPT P10636 4/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ RECQL P46063 3/20 0.41
▸ POLB P06746 2/20 0.41
▸ MPI P34949 2/20 0.41
▸ TLR2 O60603 1/20 0.41
▸ NSD2 O96028 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ GRK6 P43250 1/20 0.41
▸ TLR1 Q15399 1/20 0.41
▸ TLR6 Q9Y2C9 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ SHBG P04278 1/20 0.41
▸ HPGD P15428 2/20 0.40
▸ LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20554639 0.85 PIK3CA (0.45) PIK3CASELLSELPMAPTALDH1A1
SCHEMBL11419973 0.83 SELL (0.56) PIK3CASELLSELPHDAC1MAPT
SCHEMBL30132562 0.83 SHBG (0.55) PIK3CAMAPTALDH1A1SHBGLMNA
SCHEMBL20554833 0.83 SHBG (0.55) PIK3CAMAPTALDH1A1SHBGLMNA
SCHEMBL30132476 0.83 PIK3CA (0.41) PIK3CASELLSELPMAPTALDH1A1
SCHEMBL20554618 0.83 PIK3CA (0.41) PIK3CASELLSELPMAPTALDH1A1
SCHEMBL20554676 0.83 PIK3CA (0.40) PIK3CASELLSELPMAPTSHBG
SCHEMBL7773826 0.82 SELL (0.54) PIK3CASELLSELPHDAC1MAPT
SCHEMBL63797 0.80 ALDH1A1 (0.55) PIK3CASELLSELPHDAC1MAPT
SCHEMBL20554382 0.79 MAPT (0.42) PIK3CAMAPTKDM4EALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4275759-B1 QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER DANA FARBER CANCER INST INC (US) 2025-12-24 — — EP disclosed
US-20250034126-A1 CHROMOBOX PROTEIN INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. 2025-01-30 — — US disclosed
US-12129248-B2 Chromobox protein inhibitors and uses thereof DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-10-29 — — US disclosed
EP-4275759-A2 QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER Dana-Farber Cancer Institute, Inc. (US) 2023-11-15 — — EP disclosed
EP-4275759-A2 QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER Dana-Farber Cancer Institute, Inc. (US) 2023-11-15 — — EP disclosed
EP-3515449-B1 QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER DANA FARBER CANCER INST INC (US) 2023-07-12 — — EP disclosed
WO-2018058029-A1 CHROMOBOX PROTEIN INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-03-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034126-A1 CHROMOBOX PROTEIN INHIBITORS AND USES THEREOF CBX2, CBX3, CBX6 PIK3CA 1092/4885SELL 4860/4885SELP 4615/4885
US-12129248-B2 Chromobox protein inhibitors and uses thereof CBX2, CBX3, CBX6 PIK3CA 1092/4885SELL 4860/4885SELP 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback